Alzheimer's disease-associated neurotoxic mechanisms and neuroprotective strategies.
about
The Therapeutic Potential of Rosemary (Rosmarinus officinalis) Diterpenes for Alzheimer's DiseaseThe creatine kinase/creatine connection to Alzheimer's disease: CK-inactivation, APP-CK complexes and focal creatine depositsInhibition of beta-amyloid(1-40) Peptide Aggregation and Neurotoxicity by CitratePI3 kinase signaling is involved in Abeta-induced memory loss in Drosophila.Amyloid-beta immunotherapy for Alzheimer's diseaseCurcumin abates hypoxia-induced oxidative stress based-ER stress-mediated cell death in mouse hippocampal cells (HT22) by controlling Prdx6 and NF-κB regulation.Alzheimer's disease and genetics of inflammation: a pharmacogenomic vision.Anti-inflammatory and immune therapy for Alzheimer's disease: current status and future directions.Effect of four medicinal plants on amyloid-β induced neurotoxicity in SH-SY5Y cells.Trends in the molecular pathogenesis and clinical therapeutics of common neurodegenerative disordersSignaling through Rho GTPase pathway as viable drug target.Decreased expression of CD200 and CD200 receptor in Alzheimer's disease: a potential mechanism leading to chronic inflammation.Mitochondrial permeability transition pore in Alzheimer's disease: cyclophilin D and amyloid betaNeuroprotective properties of resveratrol and derivatives.Inflammation in the early stages of neurodegenerative pathologyFractalkine Mediates Communication between Pathogenic Proteins and Microglia: Implications of Anti-Inflammatory Treatments in Different Stages of Neurodegenerative Diseases.Protein-based biomarkers in cerebrospinal fluid and blood for Alzheimer's disease.Metallothionein-III increases ADAM10 activity in association with furin, PC7, and PKCα during non-amyloidogenic processing.Multifunctional Compound AD-35 Improves Cognitive Impairment and Attenuates the Production of TNF-α and IL-1β in an Aβ25-35-induced Rat Model of Alzheimer's Disease.Effect of phenolic compounds against Aβ aggregation and Aβ-induced toxicity in transgenic C. elegans.Bioassay-Guided Isolated Compounds from Morinda officinalis Inhibit Alzheimer's Disease Pathologies.ADAM10 activation is required for green tea (-)-epigallocatechin-3-gallate-induced alpha-secretase cleavage of amyloid precursor protein.Assessment of anti-amyloidogenic activity of marine red alga G. acerosa against Alzheimer's beta-amyloid peptide 25-35.Anti-Alzheimer's disease activity of compounds from the root bark of Morus alba L.Antioxidant and anti-cholinesterase activity of Sargassum wightii.Amyloid-beta (Aβ₁₋₄₂)-induced paralysis in Caenorhabditis elegans is inhibited by the polyphenol quercetin through activation of protein degradation pathways.Molecular Pharmacology of Rosmarinic and Salvianolic Acids: Potential Seeds for Alzheimer's and Vascular Dementia Drugs.Bifunctional phenolic-choline conjugates as anti-oxidants and acetylcholinesterase inhibitors
P2860
Q26768487-17C130EB-4CF8-424B-9E3C-E5A0DE586D11Q28200789-5E0E12C6-6DC9-4EAE-88FC-C6FE50564D59Q33514614-9CCE9B23-E624-42AB-B1FA-EE4ADA99FB3EQ33859443-FC75E8A9-3A08-4924-A826-53D04908E0C5Q33954737-E4310845-2CC5-4CB3-BF08-24549A31A285Q36763853-8A0A4ECF-F519-46A4-9AE9-EB27C9A17B9BQ37034397-AFE13652-B4CB-42D9-99EA-67DA5BCCFE61Q37101754-3976AC04-7697-41A3-8198-971832E8690AQ37224216-DA388CAF-048B-4E75-99F8-0BFFB7D219ABQ37249765-ABA0224D-7E31-4CA7-BCB8-1C7D0E204221Q37312315-E89831C4-AFBD-49F4-BCFE-D787A539C2D9Q37395599-94BF5010-AAA6-4BC5-9C34-4CA32C38AF95Q37555305-93E92B54-999C-485C-A7A4-9093025A3CA7Q37831938-954BB059-6B65-4055-9A1B-296554DC856FQ37912590-997D2598-806A-41AF-B9BD-A9B374B66EADQ38037524-39791F14-0A00-48ED-985E-CA20449EFC9DQ38222874-1DFFBF4A-AE00-4ED2-A6E6-BA63C2EB63AFQ38991860-B1BFA888-CD6A-4111-B170-300901FD661CQ46423652-45CEA3F1-9EED-4D6D-BCC3-F1122BADD932Q46962361-7F726D69-5F86-45E7-AC5E-1C245B00175CQ47726319-90A59F47-E6DB-4FA3-ADEE-0DA9A809DB07Q48577940-AE391E9A-0B9B-4292-98B0-81E0EDD615EFQ50466058-1A76159A-E822-4FC1-9C0A-01F5BD870085Q51187511-54997C3B-7186-4B33-B34B-DA685B7CE7F5Q53341989-6C665DCC-FD6F-4D12-B2EE-F00D7FA28EFCQ53355168-34396951-CD06-48F4-BCE8-B3F9D9B19649Q55093166-5EE842CC-45CA-42F2-B3FD-585B5004CF22Q56933230-C324C18E-8FB8-4F51-A3D3-DE215D36E1C2
P2860
Alzheimer's disease-associated neurotoxic mechanisms and neuroprotective strategies.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Alzheimer's disease-associated neurotoxic mechanisms and neuroprotective strategies.
@ast
Alzheimer's disease-associated neurotoxic mechanisms and neuroprotective strategies.
@en
type
label
Alzheimer's disease-associated neurotoxic mechanisms and neuroprotective strategies.
@ast
Alzheimer's disease-associated neurotoxic mechanisms and neuroprotective strategies.
@en
prefLabel
Alzheimer's disease-associated neurotoxic mechanisms and neuroprotective strategies.
@ast
Alzheimer's disease-associated neurotoxic mechanisms and neuroprotective strategies.
@en
P2093
P50
P356
P1476
Alzheimer's disease-associated neurotoxic mechanisms and neuroprotective strategies
@en
P2093
Agostinho P
Oliveira CR
P304
P356
10.2174/1568007054546117
P577
2005-08-01T00:00:00Z